A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings...

Josep Darbà, Gabriela Ramírez, Juan L García-Rivero, Sagrario Mayoralas, José Francisco Pascual, Albert Roger, Diego Vargas, Adi Bijedic
  • ClinicoEconomics and Outcomes Research, September 2016, Dove Medical Press
  • DOI: 10.2147/ceor.s111453

Spiromax versus Turbuhaler: savings in asthma costs

What is it about?

A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma

Why is it important?

A potential improvement in the inhalation technique could facilitate medication adherence. This fact would represent savings for the Healthcare System.

Perspectives

Dr. Albert Roger
Allergy Unit. University Hospital Germans Trias Pujol

Pharmacoeconomy applied to asthma treatment is a valuable pont of view.

open access logoRead Publication

http://dx.doi.org/10.2147/ceor.s111453

The following have contributed to this page: Sagrario Mayoralas Alises and Dr. Albert Roger